Altre lingue Unicycive Therapeutics, Inc.

Azioni

UNCY

US90466Y1038

Tempo reale stimato Cboe BZX Altri mercati azionari 18:27:31 10/07/2024			Variaz. 5gg	Var. 1 gen.
0,491 ^USD	+3,13%		+1,02%	-42,95%

13:03	Unicycive Therapeutics annuncia i primi risultati positivi sulla soddisfazione dei pazienti della sperimentazione clinica pivotale di Oxylanthanum Carbonate (OLC)	CI
05/07	Unicycive Therapeutics deposita una dichiarazione di registrazione per la vendita di un massimo di 50 milioni di azioni da parte degli azionisti	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings from Pivotal Clinical Trial of Oxylanthanum Carbonate (OLC)	13:03
Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings from Pivotal Clinical Trial of Oxylanthanum Carbonate	13:03
Unicycive Therapeutics Files Shelf Registration for Sale of Up to 50 Million Shares by Stockholders	05/07
Unicycive Therapeutics Joins Russell Microcap® Index	01/07
Unicycive Therapeutics, Inc.(NasdaqCM:UNCY) added to Russell Microcap Growth Index	01/07
Unicycive Therapeutics, Inc.(NasdaqCM:UNCY) added to Russell 3000E Index	01/07
Unicycive Therapeutics, Inc.(NasdaqCM:UNCY) added to Russell Microcap Index	01/07
Unicycive Therapeutics, Inc.(NasdaqCM:UNCY) added to Russell 3000E Growth Index	01/07
Unicycive Therapeutics, Inc.(NasdaqCM:UNCY) added to Russell Microcap Value Index	01/07
Unicycive Therapeutics, Inc.(NasdaqCM:UNCY) added to Russell 3000E Value Index	01/07
Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial	25/06
Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate Pivotal Clinical Trial	25/06
Unicycive Therapeutics : Oxylanthanum Carbonate (OLC) UNI OLC 201 Pivotal Trial Topline Data	25/06
Unicycive Therapeutics : June 2024 Corporate Presentation	03/06
Unicycive Therapeutics : May 2024 Corporate Presentation	29/05
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress	28/05
Unicycive Therapeutics, Inc. Delivers Multiple Presentations on Oxylanthanum Carbonate and Uni-494 At the European Renal Association Congress	28/05
Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference	23/05
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting	15/05
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate At the National Kidney Foundation Spring Clinical Meeting	15/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Unicycive Therapeutics, Inc.

Azioni

UNCY

US90466Y1038

Altre lingue

Filtri